News & Updates
Filter by Specialty:
Tumour response-speed heterogeneity linked to poor survival in metastatic colorectal cancer
01 Feb 2023
Tumour response-speed heterogeneity to first-line chemotherapy is predictive of early disease progression and shorter survival in patients with metastatic colorectal cancer, reveals a study.
Tumour response-speed heterogeneity linked to poor survival in metastatic colorectal cancer
01 Feb 2023Indomethacin plus somatostatin helps avert pancreatitis in ERCP patients
01 Feb 2023
The addition of somatostatin to rectal indomethacin is safe and effective in the prevention of postendoscopic retrograde cholangiopancreatography (post-ERCP) hypermylasemia and pancreatitis (PEP) in high-risk patients, reports a study.
Indomethacin plus somatostatin helps avert pancreatitis in ERCP patients
01 Feb 2023TNFα antagonists, non-TNF biologics both safe for treating IBD in cancer patients
20 Jan 2023
Tumour necrosis factor (TNF)-α antagonists show comparable safety as non-TNF biologics in the treatment of inflammatory bowel disease (IBD) in patients with active or recent cancer, as shown in a study.